Phase II Trial of Carmustine Plus O6-Benzylguanine for Patients With Nitrosourea-Resistant Recurrent or Progressive Malignant Glioma

Abstract
PURPOSE: We conducted a phase II trial of carmustine (BCNU) plus the O6-alkylguanine-DNA alkyltransferase inhibitor O6-benzylguanine (O6-BG) to define the activity and toxicity of this regimen in t...

This publication has 31 references indexed in Scilit: